アルビモパンの世界市場2021年

【英語タイトル】Global Alvimopan (CAS 156053-89-3) Sales Market Report 2021

QYResearchが出版した調査資料(QYR21JN7550)・商品コード:QYR21JN7550
・発行会社(調査会社):QYResearch
・発行日:2021年4月
・ページ数:134
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥660,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
QYリサーチ社の本調査レポートでは、世界のアルビモパン市場について種類別(医薬品用、その他)、用途別(医薬品、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・アルビモパン市場の概要
・世界の主要地域別アルビモパン市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界のアルビモパン市場規模2016-2021:種類別(医薬品用、その他)
・世界のアルビモパン市場予測2012-2027:種類別(医薬品用、その他)
・世界のアルビモパン市場規模2016-2021:用途別(医薬品、その他)
・世界のアルビモパン市場予測2012-2027:用途別(医薬品、その他)
・アルビモパンのアメリカ市場規模と予測2016-2021
・アルビモパンのヨーロッパ市場規模と予測2016-2021
・アルビモパンの中国市場規模と予測2016-2021
・アルビモパンの日本市場規模と予測2016-2021
・アルビモパンの東南アジア市場規模と予測2016-2021
・アルビモパンのインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Merck、Teva Pharmaceutical Industries Ltd、MSN Life Sciences Private Ltd)
・アルビモパンの製造コスト分析
・販売チャネル、流通業者、顧客
・アルビモパンの市場動向・機会・課題
・調査の結論
【レポートの概要】

Alvimopan (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
Alvimopan (CAS 156053-89-3) is widely used in Pharmaceutical and Other field. The most proportion of Alvimopan (CAS 156053-89-3) is used in Pharmaceutical, and the proportion in 2019 is 88.64%. Market competition is intense. Merck is the leaders of the industry, and they hold key technologies and patents, with high-end customers.

Market Analysis and Insights: Global Alvimopan (CAS 156053-89-3) Market
The global Alvimopan (CAS 156053-89-3) market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Alvimopan (CAS 156053-89-3) Scope and Market Size
The global Alvimopan (CAS 156053-89-3) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alvimopan (CAS 156053-89-3) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Pharmaceutical Grade
Others

Segment by Application
Pharmaceutical
Other

The Alvimopan (CAS 156053-89-3) market is analysed and market size information is provided by regions (countries). Segment by Application, the Alvimopan (CAS 156053-89-3) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Merck
Teva Pharmaceutical Industries Ltd
MSN Life Sciences Private Ltd

【レポートの目次】

1 Alvimopan (CAS 156053-89-3) Market Overview
1.1 Alvimopan (CAS 156053-89-3) Product Scope
1.2 Alvimopan (CAS 156053-89-3) Segment by Type
1.2.1 Global Alvimopan (CAS 156053-89-3) Sales by Type (2016 & 2021 & 2027)
1.2.2 Pharmaceutical Grade
1.2.3 Others
1.3 Alvimopan (CAS 156053-89-3) Segment by Application
1.3.1 Global Alvimopan (CAS 156053-89-3) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Pharmaceutical
1.3.3 Other
1.4 Alvimopan (CAS 156053-89-3) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Alvimopan (CAS 156053-89-3) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Alvimopan (CAS 156053-89-3) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Alvimopan (CAS 156053-89-3) Price Trends (2016-2027)

2 Alvimopan (CAS 156053-89-3) Estimates and Forecasts by Region
2.1 Global Alvimopan (CAS 156053-89-3) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Alvimopan (CAS 156053-89-3) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Alvimopan (CAS 156053-89-3) Sales Market Share by Region (2016-2021)
2.2.2 Global Alvimopan (CAS 156053-89-3) Revenue Market Share by Region (2016-2021)
2.3 Global Alvimopan (CAS 156053-89-3) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Alvimopan (CAS 156053-89-3) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Alvimopan (CAS 156053-89-3) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Alvimopan (CAS 156053-89-3) Estimates and Projections (2016-2027)
2.4.2 Europe Alvimopan (CAS 156053-89-3) Estimates and Projections (2016-2027)
2.4.3 China Alvimopan (CAS 156053-89-3) Estimates and Projections (2016-2027)
2.4.4 Japan Alvimopan (CAS 156053-89-3) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Alvimopan (CAS 156053-89-3) Estimates and Projections (2016-2027)
2.4.6 India Alvimopan (CAS 156053-89-3) Estimates and Projections (2016-2027)
3 Global Alvimopan (CAS 156053-89-3) Competition Landscape by Players
3.1 Global Top Alvimopan (CAS 156053-89-3) Players by Sales (2016-2021)
3.2 Global Top Alvimopan (CAS 156053-89-3) Players by Revenue (2016-2021)
3.3 Global Alvimopan (CAS 156053-89-3) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alvimopan (CAS 156053-89-3) as of 2020)
3.4 Global Alvimopan (CAS 156053-89-3) Average Price by Company (2016-2021)
3.5 Manufacturers Alvimopan (CAS 156053-89-3) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Alvimopan (CAS 156053-89-3) Market Size by Type
4.1 Global Alvimopan (CAS 156053-89-3) Historic Market Review by Type (2016-2021)
4.1.1 Global Alvimopan (CAS 156053-89-3) Sales Market Share by Type (2016-2021)
4.1.2 Global Alvimopan (CAS 156053-89-3) Revenue Market Share by Type (2016-2021)
4.1.3 Global Alvimopan (CAS 156053-89-3) Price by Type (2016-2021)
4.2 Global Alvimopan (CAS 156053-89-3) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Alvimopan (CAS 156053-89-3) Sales Forecast by Type (2022-2027)
4.2.2 Global Alvimopan (CAS 156053-89-3) Revenue Forecast by Type (2022-2027)
4.2.3 Global Alvimopan (CAS 156053-89-3) Price Forecast by Type (2022-2027)
5 Global Alvimopan (CAS 156053-89-3) Market Size by Application
5.1 Global Alvimopan (CAS 156053-89-3) Historic Market Review by Application (2016-2021)
5.1.1 Global Alvimopan (CAS 156053-89-3) Sales Market Share by Application (2016-2021)
5.1.2 Global Alvimopan (CAS 156053-89-3) Revenue Market Share by Application (2016-2021)
5.1.3 Global Alvimopan (CAS 156053-89-3) Price by Application (2016-2021)
5.2 Global Alvimopan (CAS 156053-89-3) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Alvimopan (CAS 156053-89-3) Sales Forecast by Application (2022-2027)
5.2.2 Global Alvimopan (CAS 156053-89-3) Revenue Forecast by Application (2022-2027)
5.2.3 Global Alvimopan (CAS 156053-89-3) Price Forecast by Application (2022-2027)

6 North America Alvimopan (CAS 156053-89-3) Market Facts & Figures
6.1 North America Alvimopan (CAS 156053-89-3) Sales by Company
6.1.1 North America Alvimopan (CAS 156053-89-3) Sales by Company (2016-2021)
6.1.2 North America Alvimopan (CAS 156053-89-3) Revenue by Company (2016-2021)
6.2 North America Alvimopan (CAS 156053-89-3) Sales Breakdown by Type
6.2.1 North America Alvimopan (CAS 156053-89-3) Sales Breakdown by Type (2016-2021)
6.2.2 North America Alvimopan (CAS 156053-89-3) Sales Breakdown by Type (2022-2027)
6.3 North America Alvimopan (CAS 156053-89-3) Sales Breakdown by Application
6.3.1 North America Alvimopan (CAS 156053-89-3) Sales Breakdown by Application (2016-2021)
6.3.2 North America Alvimopan (CAS 156053-89-3) Sales Breakdown by Application (2022-2027)

7 Europe Alvimopan (CAS 156053-89-3) Market Facts & Figures
7.1 Europe Alvimopan (CAS 156053-89-3) Sales by Company
7.1.1 Europe Alvimopan (CAS 156053-89-3) Sales by Company (2016-2021)
7.1.2 Europe Alvimopan (CAS 156053-89-3) Revenue by Company (2016-2021)
7.2 Europe Alvimopan (CAS 156053-89-3) Sales Breakdown by Type
7.2.1 Europe Alvimopan (CAS 156053-89-3) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Alvimopan (CAS 156053-89-3) Sales Breakdown by Type (2022-2027)
7.3 Europe Alvimopan (CAS 156053-89-3) Sales Breakdown by Application
7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)

8 China Alvimopan (CAS 156053-89-3) Market Facts & Figures
8.1 China Alvimopan (CAS 156053-89-3) Sales by Company
8.1.1 China Alvimopan (CAS 156053-89-3) Sales by Company (2016-2021)
8.1.2 China Alvimopan (CAS 156053-89-3) Revenue by Company (2016-2021)
8.2 China Alvimopan (CAS 156053-89-3) Sales Breakdown by Type
8.2.1 China Alvimopan (CAS 156053-89-3) Sales Breakdown by Type (2016-2021)
8.2.2 China Alvimopan (CAS 156053-89-3) Sales Breakdown by Type (2022-2027)
8.3 China Alvimopan (CAS 156053-89-3) Sales Breakdown by Application
8.3.1 China 242 Sales Breakdown by Application (2016-2021)
8.3.2 China 242 Sales Breakdown by Application (2022-2027)

9 Japan Alvimopan (CAS 156053-89-3) Market Facts & Figures
9.1 Japan Alvimopan (CAS 156053-89-3) Sales by Company
9.1.1 Japan Alvimopan (CAS 156053-89-3) Sales by Company (2016-2021)
9.1.2 Japan Alvimopan (CAS 156053-89-3) Revenue by Company (2016-2021)
9.2 Japan Alvimopan (CAS 156053-89-3) Sales Breakdown by Type
9.2.1 Japan Alvimopan (CAS 156053-89-3) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Alvimopan (CAS 156053-89-3) Sales Breakdown by Type (2022-2027)
9.3 Japan Alvimopan (CAS 156053-89-3) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Alvimopan (CAS 156053-89-3) Market Facts & Figures
10.1 Southeast Asia Alvimopan (CAS 156053-89-3) Sales by Company
10.1.1 Southeast Asia Alvimopan (CAS 156053-89-3) Sales by Company (2016-2021)
10.1.2 Southeast Asia Alvimopan (CAS 156053-89-3) Revenue by Company (2016-2021)
10.2 Southeast Asia Alvimopan (CAS 156053-89-3) Sales Breakdown by Type
10.2.1 Southeast Asia Alvimopan (CAS 156053-89-3) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Alvimopan (CAS 156053-89-3) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Alvimopan (CAS 156053-89-3) Sales Breakdown by Application
10.3.1 Southeast Asia KG Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia KG Sales Breakdown by Application (2022-2027)

11 India Alvimopan (CAS 156053-89-3) Market Facts & Figures
11.1 India Alvimopan (CAS 156053-89-3) Sales by Company
11.1.1 India Alvimopan (CAS 156053-89-3) Sales by Company (2016-2021)
11.1.2 India Alvimopan (CAS 156053-89-3) Revenue by Company (2016-2021)
11.2 India Alvimopan (CAS 156053-89-3) Sales Breakdown by Type
11.2.1 India Alvimopan (CAS 156053-89-3) Sales Breakdown by Type (2016-2021)
11.2.2 India Alvimopan (CAS 156053-89-3) Sales Breakdown by Type (2022-2027)
11.3 India Alvimopan (CAS 156053-89-3) Sales Breakdown by Application
11.3.1 India Alvimopan (CAS 156053-89-3) Sales Breakdown by Application (2016-2021)
11.3.2 India Alvimopan (CAS 156053-89-3) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Alvimopan (CAS 156053-89-3) Business
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Business Overview
12.1.3 Merck Alvimopan (CAS 156053-89-3) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Alvimopan (CAS 156053-89-3) Products Offered
12.1.5 Merck Recent Development
12.2 Teva Pharmaceutical Industries Ltd
12.2.1 Teva Pharmaceutical Industries Ltd Corporation Information
12.2.2 Teva Pharmaceutical Industries Ltd Business Overview
12.2.3 Teva Pharmaceutical Industries Ltd Alvimopan (CAS 156053-89-3) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Teva Pharmaceutical Industries Ltd Alvimopan (CAS 156053-89-3) Products Offered
12.2.5 Teva Pharmaceutical Industries Ltd Recent Development
12.3 MSN Life Sciences Private Ltd
12.3.1 MSN Life Sciences Private Ltd Corporation Information
12.3.2 MSN Life Sciences Private Ltd Business Overview
12.3.3 MSN Life Sciences Private Ltd Alvimopan (CAS 156053-89-3) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 MSN Life Sciences Private Ltd Alvimopan (CAS 156053-89-3) Products Offered
12.3.5 MSN Life Sciences Private Ltd Recent Development

13 Alvimopan (CAS 156053-89-3) Manufacturing Cost Analysis
13.1 Alvimopan (CAS 156053-89-3) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Alvimopan (CAS 156053-89-3)
13.4 Alvimopan (CAS 156053-89-3) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Alvimopan (CAS 156053-89-3) Distributors List
14.3 Alvimopan (CAS 156053-89-3) Customers

15 Market Dynamics
15.1 Alvimopan (CAS 156053-89-3) Market Trends
15.2 Alvimopan (CAS 156053-89-3) Drivers
15.3 Alvimopan (CAS 156053-89-3) Market Challenges
15.4 Alvimopan (CAS 156053-89-3) Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Alvimopan (CAS 156053-89-3) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Alvimopan (CAS 156053-89-3) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Alvimopan (CAS 156053-89-3) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Alvimopan (CAS 156053-89-3) Sales (KG) by Region (2016-2021)
Table 5. Global Alvimopan (CAS 156053-89-3) Sales Market Share by Region (2016-2021)
Table 6. Global Alvimopan (CAS 156053-89-3) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Alvimopan (CAS 156053-89-3) Revenue Share by Region (2016-2021)
Table 8. Global Alvimopan (CAS 156053-89-3) Sales (KG) Forecast by Region (2022-2027)
Table 9. Global Alvimopan (CAS 156053-89-3) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Alvimopan (CAS 156053-89-3) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Alvimopan (CAS 156053-89-3) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Alvimopan (CAS 156053-89-3) Sales (KG) of Key Companies (2016-2021)
Table 13. Global Alvimopan (CAS 156053-89-3) Sales Share by Company (2016-2021)
Table 14. Global Alvimopan (CAS 156053-89-3) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Alvimopan (CAS 156053-89-3) Revenue Share by Company (2016-2021)
Table 16. Global Alvimopan (CAS 156053-89-3) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alvimopan (CAS 156053-89-3) as of 2020)
Table 17. Global Alvimopan (CAS 156053-89-3) Average Price (US$/g) of Key Company (2016-2021)
Table 18. Manufacturers Alvimopan (CAS 156053-89-3) Manufacturing Sites and Area Served
Table 19. Manufacturers Alvimopan (CAS 156053-89-3) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Alvimopan (CAS 156053-89-3) Sales (KG) by Type (2016-2021)
Table 22. Global Alvimopan (CAS 156053-89-3) Sales Share by Type (2016-2021)
Table 23. Global Alvimopan (CAS 156053-89-3) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Alvimopan (CAS 156053-89-3) Price (US$/g) by Type (2016-2021)
Table 25. Global Alvimopan (CAS 156053-89-3) Sales Share by Type (2022-2027)
Table 26. Global Alvimopan (CAS 156053-89-3) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Alvimopan (CAS 156053-89-3) Revenue Share by Type (2022-2027)
Table 28. Global Alvimopan (CAS 156053-89-3) Price (US$/g) by Type (2022-2027)
Table 29. Global Alvimopan (CAS 156053-89-3) Sales (KG) by Application (2016-2021)
Table 30. Global Alvimopan (CAS 156053-89-3) Sales Share by Application (2016-2021)
Table 31. Global Alvimopan (CAS 156053-89-3) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Alvimopan (CAS 156053-89-3) Price (US$/g) by Application (2016-2021)
Table 33. Global Alvimopan (CAS 156053-89-3) Sales (KG) by Application (2022-2027)
Table 34. Global Alvimopan (CAS 156053-89-3) Sales Share by Application (2022-2027)
Table 35. Global Alvimopan (CAS 156053-89-3) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Alvimopan (CAS 156053-89-3) Revenue Share by Application (2022-2027)
Table 37. Global Alvimopan (CAS 156053-89-3) Price (US$/g) by Application (2022-2027)
Table 38. North America Alvimopan (CAS 156053-89-3) Sales (KG) by Company (2016-2021)
Table 39. North America Alvimopan (CAS 156053-89-3) Sales Market Share by Company (2016-2021)
Table 40. North America Alvimopan (CAS 156053-89-3) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Alvimopan (CAS 156053-89-3) Revenue Market Share by Company (2016-2021)
Table 42. North America Alvimopan (CAS 156053-89-3) Sales by Type (2016-2021) & (KG)
Table 43. North America Alvimopan (CAS 156053-89-3) Sales Market Share by Type (2016-2021)
Table 44. North America Alvimopan (CAS 156053-89-3) Sales by Type (2022-2027) & (KG)
Table 45. North America Alvimopan (CAS 156053-89-3) Sales Market Share by Type (2022-2027)
Table 46. North America Alvimopan (CAS 156053-89-3) Sales by Application (2016-2021) & (KG)
Table 47. North America Alvimopan (CAS 156053-89-3) Sales Market Share by Application (2016-2021)
Table 48. North America Alvimopan (CAS 156053-89-3) Sales by Application (2022-2027) & (KG)
Table 49. North America Alvimopan (CAS 156053-89-3) Sales Market Share by Application (2022-2027)
Table 50. Europe Alvimopan (CAS 156053-89-3) Sales (KG) by Company (2016-2021)
Table 51. Europe Alvimopan (CAS 156053-89-3) Sales Market Share by Company (2016-2021)
Table 52. Europe Alvimopan (CAS 156053-89-3) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Alvimopan (CAS 156053-89-3) Revenue Market Share by Company (2016-2021)
Table 54. Europe Alvimopan (CAS 156053-89-3) Sales by Type (2016-2021) & (KG)
Table 55. Europe Alvimopan (CAS 156053-89-3) Sales Market Share by Type (2016-2021)
Table 56. Europe Alvimopan (CAS 156053-89-3) Sales by Type (2022-2027) & (KG)
Table 57. Europe Alvimopan (CAS 156053-89-3) Sales Market Share by Type (2022-2027)
Table 58. Europe Alvimopan (CAS 156053-89-3) Sales by Application (2016-2021) & (KG)
Table 59. Europe Alvimopan (CAS 156053-89-3) Sales Market Share by Application (2016-2021)
Table 60. Europe Alvimopan (CAS 156053-89-3) Sales by Application (2022-2027) & (KG)
Table 61. Europe Alvimopan (CAS 156053-89-3) Sales Market Share by Application (2022-2027)
Table 62. China Alvimopan (CAS 156053-89-3) Sales (KG) by Company (2016-2021)
Table 63. China Alvimopan (CAS 156053-89-3) Sales Market Share by Company (2016-2021)
Table 64. China Alvimopan (CAS 156053-89-3) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Alvimopan (CAS 156053-89-3) Revenue Market Share by Company (2016-2021)
Table 66. China Alvimopan (CAS 156053-89-3) Sales by Type (2016-2021) & (KG)
Table 67. China Alvimopan (CAS 156053-89-3) Sales Market Share by Type (2016-2021)
Table 68. China Alvimopan (CAS 156053-89-3) Sales by Type (2022-2027) & (KG)
Table 69. China Alvimopan (CAS 156053-89-3) Sales Market Share by Type (2022-2027)
Table 70. China Alvimopan (CAS 156053-89-3) Sales by Application (2016-2021) & (KG)
Table 71. China Alvimopan (CAS 156053-89-3) Sales Market Share by Application (2016-2021)
Table 72. China Alvimopan (CAS 156053-89-3) Sales by Application (2022-2027) & (KG)
Table 73. China Alvimopan (CAS 156053-89-3) Sales Market Share by Application (2022-2027)
Table 74. Japan Alvimopan (CAS 156053-89-3) Sales (KG) by Company (2016-2021)
Table 75. Japan Alvimopan (CAS 156053-89-3) Sales Market Share by Company (2016-2021)
Table 76. Japan Alvimopan (CAS 156053-89-3) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Alvimopan (CAS 156053-89-3) Revenue Market Share by Company (2016-2021)
Table 78. Japan Alvimopan (CAS 156053-89-3) Sales by Type (2016-2021) & (KG)
Table 79. Japan Alvimopan (CAS 156053-89-3) Sales Market Share by Type (2016-2021)
Table 80. Japan Alvimopan (CAS 156053-89-3) Sales by Type (2022-2027) & (KG)
Table 81. Japan Alvimopan (CAS 156053-89-3) Sales Market Share by Type (2022-2027)
Table 82. Japan Alvimopan (CAS 156053-89-3) Sales by Application (2016-2021) & (KG)
Table 83. Japan Alvimopan (CAS 156053-89-3) Sales Market Share by Application (2016-2021)
Table 84. Japan Alvimopan (CAS 156053-89-3) Sales by Application (2022-2027) & (KG)
Table 85. Japan Alvimopan (CAS 156053-89-3) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Alvimopan (CAS 156053-89-3) Sales (KG) by Company (2016-2021)
Table 87. Southeast Asia Alvimopan (CAS 156053-89-3) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Alvimopan (CAS 156053-89-3) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Alvimopan (CAS 156053-89-3) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Alvimopan (CAS 156053-89-3) Sales by Type (2016-2021) & (KG)
Table 91. Southeast Asia Alvimopan (CAS 156053-89-3) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Alvimopan (CAS 156053-89-3) Sales by Type (2022-2027) & (KG)
Table 93. Southeast Asia Alvimopan (CAS 156053-89-3) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Alvimopan (CAS 156053-89-3) Sales by Application (2016-2021) & (KG)
Table 95. Southeast Asia Alvimopan (CAS 156053-89-3) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Alvimopan (CAS 156053-89-3) Sales by Application (2022-2027) & (KG)
Table 97. Southeast Asia Alvimopan (CAS 156053-89-3) Sales Market Share by Application (2022-2027)
Table 98. India Alvimopan (CAS 156053-89-3) Sales (KG) by Company (2016-2021)
Table 99. India Alvimopan (CAS 156053-89-3) Sales Market Share by Company (2016-2021)
Table 100. India Alvimopan (CAS 156053-89-3) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Alvimopan (CAS 156053-89-3) Revenue Market Share by Company (2016-2021)
Table 102. India Alvimopan (CAS 156053-89-3) Sales by Type (2016-2021) & (KG)
Table 103. India Alvimopan (CAS 156053-89-3) Sales Market Share by Type (2016-2021)
Table 104. India Alvimopan (CAS 156053-89-3) Sales by Type (2022-2027) & (KG)
Table 105. India Alvimopan (CAS 156053-89-3) Sales Market Share by Type (2022-2027)
Table 106. India Alvimopan (CAS 156053-89-3) Sales by Application (2016-2021) & (KG)
Table 107. India Alvimopan (CAS 156053-89-3) Sales Market Share by Application (2016-2021)
Table 108. India Alvimopan (CAS 156053-89-3) Sales by Application (2022-2027) & (KG)
Table 109. India Alvimopan (CAS 156053-89-3) Sales Market Share by Application (2022-2027)
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck Alvimopan (CAS 156053-89-3) Sales (KG), Revenue (Million USD), Price (US$/g) and Gross Margin (2016-2021)
Table 113. Merck Alvimopan (CAS 156053-89-3) Product
Table 114. Merck Recent Development
Table 115. Teva Pharmaceutical Industries Ltd Corporation Information
Table 116. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 117. Teva Pharmaceutical Industries Ltd Alvimopan (CAS 156053-89-3) Sales (KG), Revenue (Million USD), Price (US$/g) and Gross Margin (2016-2021)
Table 118. Teva Pharmaceutical Industries Ltd Alvimopan (CAS 156053-89-3) Product
Table 119. Teva Pharmaceutical Industries Ltd Recent Development
Table 120. MSN Life Sciences Private Ltd Corporation Information
Table 121. MSN Life Sciences Private Ltd Description and Business Overview
Table 122. MSN Life Sciences Private Ltd Alvimopan (CAS 156053-89-3) Sales (KG), Revenue (Million USD), Price (US$/g) and Gross Margin (2016-2021)
Table 123. MSN Life Sciences Private Ltd Alvimopan (CAS 156053-89-3) Product
Table 124. MSN Life Sciences Private Ltd Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Alvimopan (CAS 156053-89-3) Distributors List
Table 128. Alvimopan (CAS 156053-89-3) Customers List
Table 129. Alvimopan (CAS 156053-89-3) Market Trends
Table 130. Alvimopan (CAS 156053-89-3) Market Drivers
Table 131. Alvimopan (CAS 156053-89-3) Market Challenges
Table 132. Alvimopan (CAS 156053-89-3) Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Alvimopan (CAS 156053-89-3) Product Picture
Figure 2. Global Alvimopan (CAS 156053-89-3) Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Alvimopan (CAS 156053-89-3) Sales Market Share by Application in 2021 & 2027
Figure 6. Pharmaceutical Examples
Figure 7. Other Examples
Figure 8. Global Alvimopan (CAS 156053-89-3) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Alvimopan (CAS 156053-89-3) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Alvimopan (CAS 156053-89-3) Sales (KG) Growth Rate (2016-2027)
Figure 11. Global Alvimopan (CAS 156053-89-3) Price Trends Growth Rate (2016-2027) (US$/g)
Figure 12. Global Alvimopan (CAS 156053-89-3) Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Alvimopan (CAS 156053-89-3) Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Alvimopan (CAS 156053-89-3) Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Alvimopan (CAS 156053-89-3) Sales (KG) Growth Rate (2016-2027)
Figure 16. Europe Alvimopan (CAS 156053-89-3) Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Alvimopan (CAS 156053-89-3) Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Alvimopan (CAS 156053-89-3) Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Alvimopan (CAS 156053-89-3) Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Alvimopan (CAS 156053-89-3) Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Alvimopan (CAS 156053-89-3) Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Alvimopan (CAS 156053-89-3) Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Alvimopan (CAS 156053-89-3) Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Alvimopan (CAS 156053-89-3) Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Alvimopan (CAS 156053-89-3) Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Alvimopan (CAS 156053-89-3) Players Market Share by Revenue in Alvimopan (CAS 156053-89-3): 2016 & 2020
Figure 27. Alvimopan (CAS 156053-89-3) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Alvimopan (CAS 156053-89-3) Revenue Share by Type (2016-2021)
Figure 29. Global Alvimopan (CAS 156053-89-3) Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Alvimopan (CAS 156053-89-3) Revenue Share by Application (2016-2021)
Figure 31. Global Alvimopan (CAS 156053-89-3) Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Alvimopan (CAS 156053-89-3) Sales Market Share by Type in 2020
Figure 33. North America Alvimopan (CAS 156053-89-3) Sales Market Share by Application in 2020
Figure 34. Europe Alvimopan (CAS 156053-89-3) Sales Market Share by Type in 2020
Figure 35. Europe Alvimopan (CAS 156053-89-3) Sales Market Share by Application in 2020
Figure 36. China Alvimopan (CAS 156053-89-3) Sales Market Share by Type in 2020
Figure 37. China Alvimopan (CAS 156053-89-3) Sales Market Share by Application in 2020
Figure 38. Japan Alvimopan (CAS 156053-89-3) Sales Market Share by Type in 2020
Figure 39. Japan Alvimopan (CAS 156053-89-3) Sales Market Share by Application in 2020
Figure 40. Southeast Asia Alvimopan (CAS 156053-89-3) Sales Market Share by Type in 2020
Figure 41. Southeast Asia Alvimopan (CAS 156053-89-3) Sales Market Share by Application in 2020
Figure 42. India Alvimopan (CAS 156053-89-3) Sales Market Share by Type in 2020
Figure 43. India Alvimopan (CAS 156053-89-3) Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Alvimopan (CAS 156053-89-3)
Figure 46. Manufacturing Process Analysis of Alvimopan (CAS 156053-89-3)
Figure 47. Alvimopan (CAS 156053-89-3) Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed


【掲載企業】

Merck、Teva Pharmaceutical Industries Ltd、MSN Life Sciences Private Ltd

★調査レポート[アルビモパンの世界市場2021年] (コード:QYR21JN7550)販売に関する免責事項を必ずご確認ください。
★調査レポート[アルビモパンの世界市場2021年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆